Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic.
Benusiglio PR, Korenbaum C, Vibert R, Ezenfis J, Geoffron S, Paul C, Richard S, Byrde V, Lejeune M, Guillerm E, Basset N, Lotz JP, Chabbert-Buffet N, Gligorov J, Coulet F.
Benusiglio PR, et al. Among authors: lotz jp.
Eur J Med Genet. 2020 Dec;63(12):104098. doi: 10.1016/j.ejmg.2020.104098. Epub 2020 Nov 10.
Eur J Med Genet. 2020.
PMID: 33186762
Free PMC article.